The US Food and Drug Administration (FDA) has announced that Tracy Beth Høeg has been appointed acting director of the Center ...
The UK’s BioIndustry Association (BIA) today released its report, From innovation to impact: unlocking patient access to ...
Accession Therapeutics, a UK clinical-stage biopharmaceutical company developing next generation cancer immunotherapies, ...
US rare diseases focused biotech Capricor Therapeutics shares closed up 371% at $29.96, having leapt a staggering 500% ...
A new Australian biotech, Evinco Therapeutics, has launched in Melbourne to advance immune-based treatments for Alzheimer’s ...
Bristol Myers Squibb (NYSE: BMY) is bringing fresh participants into its Phase III ADEPT-2 trial of Cobenfy ...
Dutch biotech Laigo Bio has launched with 11.5 million euros ($12.7 million) in seed financing to progress its SureTAC ...
IDA Ireland has released a new whitepaper setting out how the country intends to strengthen its role as a global center for ...
US oncology specialist Crescent Biopharma has announced an exclusive partnership with China’s Sichuan Kelun-Biotech ...
Excelsior Sciences has secured $95 million to scale what it calls a new, machine-native approach to small-molecule chemistry, ...
The US Food and Drug Administration (FDA) has granted traditional approval to Eli Lilly’s Jaypirca (pirtobrutinib, 100mg an ...
Germany’s Formycon and Jordan-based MS Pharma have entered into an exclusive licensing and supply agreement for the commercialization of FYB206, Formycon’s biosimilar candidate to the blockbuster drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback